Abstract
Zn(II)-phthalocyanine (Zn-Pc) incorporated into unilamellar liposomes of dipalmitoylphosphatidylcholine has been injected intraperitoneally (0.5 mg kg-1) to BALB/c mice bearing a transplanted MS-2 fibrosarcoma. The drug is specifically transported by serum lipoproteins and cleared from the serum via the bile-gut pathway in a biphasic process: approximately 60% of Zn-Pc is eliminated with a serum half-life of approximately 9 hours, while the remaining aliquot is eliminated at a very slow rate. Several normal tissues take up the drug within 3 hours after administration but release it almost completely after 24-48 hours. On the other hand, the tumour shows a maximum concentration of Zn-Pc (approximately 0.6 microgram g-1 of tissue) after 18-24 hours; at this time, the ratio between the Zn-Pc levels in the tumour and the muscle (which represents the surrounding normal tissue) is approximately 7.5. The results are discussed in terms of a possible use of Zn-Pc as a photosensitizer in the photodynamic therapy of tumours.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Reddi, E., Lo Castro, G., Biolo, R. et al. Pharmacokinetic studies with zinc(II)-phthalocyanine in tumour-bearing mice. Br J Cancer 56, 597–600 (1987). https://doi.org/10.1038/bjc.1987.247
Issue Date:
DOI: https://doi.org/10.1038/bjc.1987.247
This article is cited by
-
132-hydroxy-bacteriopheophorbidea-methylester pharmacokinetics in mice bearing Lewis lung carcinoma
Lasers in Medical Science (1998)
-
Experimental photodynamic therapy with tetrapropyl-porphycene: Ultrastructural studies on the mechanism of tumour photodamage
Lasers in Medical Science (1991)
-
Liposome- or LDL-administered Zn(II)-phthalocyanine as a photodynamic agent for tumours III. Effect of cholesterol on pharmacokinetic and phototherapeutic properties
Lasers in Medical Science (1990)
-
Factors controlling the selectivity and efficiency of tumour damage in photodynamic therapy
Lasers in Medical Science (1990)
-
Comparison of lasers for photodynamic therapy with a phthalocyanine photosensitizer
Lasers in Medical Science (1989)